CSIMarket



Best Performing Stocks In Healthcare Sector Today



 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 
 

Shares declined by -0.5% on average, in Healthcare Sector today.

Here are the best performing stocks in Healthcare Sector.




MBIO

$0.75

$0.6200 476.92%
Today's


MBIO

$0.75

$0.6200 476.92%



Mustang Bio inc

Mustang Bio Inc shares increased 476.92% today.


Mustang Bio Inc operates on a business model focused on developing advanced therapies for challenging diseases. They primarily engage in research, development, and commercialization of innovative gene and cell therapies. Mustang Bio Inc aims to provide cutting-edge treatments to patients in need by leveraging its expertise in gene editing technologies and strategic partnerships.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.129 mill. $ - mill. $ -70.209 mill. 8 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 6.129 mill.


$ - mill.


$ -70.209 mill.

Employees Shares Outstanding P/E

330


8 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



VAPO

$2.11

$1.2900 157.32%
Today's


VAPO

$2.11

$1.2900 157.32%



Vapotherm Inc

Vapotherm Inc shares improved 157.32% today.


Vapotherm Inc operates under a business model that focuses on providing innovative respiratory support solutions to hospitals and healthcare facilities. They offer high-flow therapy systems and devices that deliver heated, humidified, and oxygenated air to patients with respiratory issues, aiming to improve patient outcomes and reduce the need for invasive interventions. Through strategic partnerships with hospitals and direct sales to healthcare providers, Vapotherm aims to both improve patient care and generate revenue from the sales of their products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13.422 mill. $ 67.598 mill. $ -69.445 mill. 6 mill. - Y/Y 11.97 %
Market Cap. Revenues TTM Net Income TTM

$ 13.422 mill.


$ 67.598 mill.


$ -69.445 mill.

Employees Shares Outstanding P/E

-


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 11.97 %


MRQ Y/Y - %



SCNI

$5.6

$2.1100 60.46%
Today's


SCNI

$5.6

$2.1100 60.46%



Scinai Immunotherapeutics Ltd

Scinai Immunotherapeutics Ltd shares improved 60.46% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 875.071 mill. $ - mill. $ 6.500 mill. 156 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 875.071 mill.


$ - mill.


$ 6.500 mill.

Employees Shares Outstanding P/E

-


156 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y 0.00 %



CALA

$0.02

$0.0075 60.00%
Today's


CALA

$0.02

$0.0075 60.00%



Calithera Biosciences Inc

Calithera Biosciences Inc shares went up 60.00% today.


Calithera Biosciences Inc is a biotechnology company that specializes in developing novel small molecule drugs to treat and potentially cure cancer. Their business model focuses on leveraging their expertise in tumor metabolism to discover and develop innovative therapies that target specific enzymes and pathways involved in cancer cell growth and survival.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.114 mill. $ - mill. $ -21.290 mill. 6 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.114 mill.


$ - mill.


$ -21.290 mill.

Employees Shares Outstanding P/E

-


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AZTR

$0.2337

$0.0844 56.53%
Today's


AZTR

$0.2337

$0.0844 56.53%



Azitra Inc

Azitra Inc shares went up 56.53% today.


Azitra Inc is a company that operates on a business model focused on developing and commercializing microbiome-based therapeutics for various skin conditions. It aims to use the potential of the human skin microbiome to develop innovative and effective treatments.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.717 mill. $ - mill. $ -14.217 mill. 20 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 4.717 mill.


$ - mill.


$ -14.217 mill.

Employees Shares Outstanding P/E

-


20 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



GSTC

$0.0009

$0.0003 50.00%
Today's


GSTC

$0.0009

$0.0003 50.00%



Globestar Therapeutics Corporation

Globestar Therapeutics Corporation stock increased 50.00% today.


Globestar Therapeutics Corporation*s business model is focused on providing therapeutic solutions through innovative products and services aimed at improving healthcare outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.904 mill. $ - mill. $ -1.947 mill. 1,004 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.904 mill.


$ - mill.


$ -1.947 mill.

Employees Shares Outstanding P/E

-


1,004 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NDRA

$0.139

$0.0354 34.17%
Today's


NDRA

$0.139

$0.0354 34.17%



Endra Life Sciences Inc

Endra Life Sciences Inc stock went up 34.17% today.


Endra Life Sciences Inc*s business model focuses on developing and commercializing advanced imaging technologies and solutions for medical and industrial applications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.502 mill. $ - mill. $ -9.893 mill. 11 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.502 mill.


$ - mill.


$ -9.893 mill.

Employees Shares Outstanding P/E

-


11 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



SCLX

$2.15

$0.5400 33.54%
Today's


SCLX

$2.15

$0.5400 33.54%



Scilex Holding Company

Scilex Holding Company stock went up 33.54% today.


Scilex Holding Company operates as a pharmaceutical company focused on the development and commercialization of prescription drugs. Through its business model, it aims to identify and acquire assets that have the potential to address unmet medical needs and improve patient outcomes. The company primarily focuses on developing innovative, differentiated products in the therapeutic areas of pain management and neurology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 300.587 mill. $ 71.315 mill. $ -116.919 mill. 140 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 300.587 mill.


$ 71.315 mill.


$ -116.919 mill.

Employees Shares Outstanding P/E

-


140 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NLSP

$0.1483

$0.0344 30.20%
Today's


NLSP

$0.1483

$0.0344 30.20%



Nls Pharmaceutics Ltd

Nls Pharmaceutics Ltd shares went up 30.20% today.


Nls Pharmaceutics Ltd is a pharmaceutical company with a business model centered around research, development, and commercialization of innovative drug therapies. They focus on designing and formulating novel drug delivery systems that improve the efficacy and safety of existing medications. Nls Pharmaceutics aims to bring their advanced drug delivery technologies to market by partnering with larger pharmaceutical companies or seeking regulatory approval for their own products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.662 mill. $ - mill. $ -12.172 mill. 38 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 5.662 mill.


$ - mill.


$ -12.172 mill.

Employees Shares Outstanding P/E

-


38 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MIRM

$33

$7.0800 27.31%
Today's


MIRM

$33

$7.0800 27.31%



Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc shares improved 27.31% today.


Mirum Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing innovative therapies for patients with rare liver diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,548.609 mill. $ 186.042 mill. $ -153.035 mill. 47 mill. - Y/Y 148.05 %
Market Cap. Revenues TTM Net Income TTM

$ 1,548.609 mill.


$ 186.042 mill.


$ -153.035 mill.

Employees Shares Outstanding P/E

-


47 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 148.05 %


MRQ Y/Y - %



SINT

$6.06

$1.2300 25.47%
Today's


SINT

$6.06

$1.2300 25.47%



Sintx Technologies Inc

Sintx Technologies Inc shares improved 25.47% today.


Sintx Technologies Inc is a company that operates under a business model focused on developing and commercializing silicon nitride-based ceramics for various applications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 208.833 mill. $ 2.775 mill. $ -8.852 mill. 34 mill. - Y/Y 27.46 %
Market Cap. Revenues TTM Net Income TTM

$ 208.833 mill.


$ 2.775 mill.


$ -8.852 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 27.46 %


MRQ Y/Y - %



ENZN

$0.17

$0.0298 21.26%
Today's


ENZN

$0.17

$0.0298 21.26%



Enzon Pharmaceuticals inc

Enzon Pharmaceuticals Inc shares went up 21.26% today.


Enzon Pharmaceuticals Inc. operates under a business model that focuses on the research, development, and commercialization of therapeutic drugs to address unmet medical needs. The company primarily employs a licensing strategy, partnering with other pharmaceutical companies to advance their drug candidates through clinical development and regulatory approval. By leveraging collaborations and out-licensing opportunities, Enzon aims to bring new therapies to market efficiently while maximizing shareholder value.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 12.617 mill. $ 2.461 mill. $ 1.496 mill. 74 mill. 25,475.24 Y/Y 44.74 %
Market Cap. Revenues TTM Net Income TTM

$ 12.617 mill.


$ 2.461 mill.


$ 1.496 mill.

Employees Shares Outstanding P/E

-


74 mill.


25,475.24

Revenue Growth Income Growth

MRQ Y/Y 44.74 %


MRQ Y/Y 62.44 %



BRTX

$2.22

$0.3700 20.00%
Today's


BRTX

$2.22

$0.3700 20.00%



Biorestorative Therapies Inc

Biorestorative Therapies Inc shares improved 20.00% today.


Biorestorative Therapies Inc (BRTX) is a biotechnology company that focuses on developing and commercializing regenerative therapies using cell and tissue protocols. Their business model entails researching, acquiring, and licensing new technologies and proprietary stem cell techniques, which are utilized to develop therapeutic products for various medical conditions. BRTX aims to collaborate with research institutions, healthcare providers, and industry partners to advance the field of regenerative medicine and bring novel treatments to patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9.357 mill. $ 0.121 mill. $ -14.107 mill. 4 mill. - Y/Y -27.59 %
Market Cap. Revenues TTM Net Income TTM

$ 9.357 mill.


$ 0.121 mill.


$ -14.107 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -27.59 %


MRQ Y/Y - %



XTLB

$2.44

$0.4000 19.61%
Today's


XTLB

$2.44

$0.4000 19.61%



Xtl Biopharmaceuticals Ltd

Xtl Biopharmaceuticals Ltd stock went up 19.61% today.


Xtl Biopharmaceuticals Ltd*s business model revolves around developing and commercializing innovative biopharmaceutical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,329.571 mill. $ - mill. $ 0.000 mill. 545 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1,329.571 mill.


$ - mill.


$ 0.000 mill.

Employees Shares Outstanding P/E

-


545 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



GLSI

$17.44

$2.6800 18.16%
Today's


GLSI

$17.44

$2.6800 18.16%



Greenwich Lifesciences Inc

Greenwich Lifesciences Inc stock increased 18.16% today.


Greenwich Lifesciences Inc*s business model focuses on the research, development, and commercialization of innovative therapies in the field of oncology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 224.273 mill. $ - mill. $ -8.618 mill. 13 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 224.273 mill.


$ - mill.


$ -8.618 mill.

Employees Shares Outstanding P/E

-


13 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ATNF

$1.83

$0.2800 18.06%
Today's


ATNF

$1.83

$0.2800 18.06%



180 Life Sciences Corp

180 Life Sciences Corp stock increased 18.06% today.


180 Life Sciences Corp is a biotechnology company engaged in the research and development of novel drugs that target inflammation and fibrosis to address various diseases such as fibrosis, inflammation, and pain.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.766 mill. $ - mill. $ -40.450 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.766 mill.


$ - mill.


$ -40.450 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



SER

$12.8

$1.7900 16.26%
Today's


SER

$12.8

$1.7900 16.26%



Serina Therapeutics Inc

Serina Therapeutics Inc stock increased 16.26% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 35.712 mill. $ 0.138 mill. $ -21.812 mill. 3 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 35.712 mill.


$ 0.138 mill.


$ -21.812 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NWBO

$0.4977

$0.0657 15.21%
Today's


NWBO

$0.4977

$0.0657 15.21%



Northwest Biotherapeutics inc

Northwest Biotherapeutics Inc shares improved 15.21% today.


Northwest Biotherapeutics Inc*s business model focuses on the development and commercialization of personalized immunotherapy products for the treatment of cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.591 mill. $ 1.771 mill. $ -63.993 mill. 1 mill. - Y/Y -52.43 %
Market Cap. Revenues TTM Net Income TTM

$ 0.591 mill.


$ 1.771 mill.


$ -63.993 mill.

Employees Shares Outstanding P/E

16


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -52.43 %


MRQ Y/Y - %



AVAH

$2.85

$0.3700 14.92%
Today's


AVAH

$2.85

$0.3700 14.92%



Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc stock increased 14.92% today.


Aveanna Healthcare Holdings Inc operates as a provider of home healthcare services for pediatric patients with complex medical needs. They offer a comprehensive range of medical services and support to these patients, delivered by a team of healthcare professionals in the comfort of their own homes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 539.046 mill. $ 1,867.515 mill. $ -346.567 mill. 189 mill. - Y/Y 7.90 %
Market Cap. Revenues TTM Net Income TTM

$ 539.046 mill.


$ 1,867.515 mill.


$ -346.567 mill.

Employees Shares Outstanding P/E

-


189 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 7.90 %


MRQ Y/Y - %



MRKR

$4.78

$0.6153 14.77%
Today's


MRKR

$4.78

$0.6153 14.77%



Marker Therapeutics inc

Marker Therapeutics Inc shares increased 14.77% today.


Marker Therapeutics Inc is a biotechnology company that aims to develop and commercialize novel T cell immunotherapies for the treatment of cancer. Their business model focuses on leveraging their expertise in cellular engineering to develop proprietary technologies and therapies that can be licensed or partnered with other organizations for further development and commercialization.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 42.551 mill. $ -0.179 mill. $ -5.662 mill. 9 mill. - Y/Y -73.72 %
Market Cap. Revenues TTM Net Income TTM

$ 42.551 mill.


$ -0.179 mill.


$ -5.662 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -73.72 %


MRQ Y/Y - %



ARDS

$0.0687

$0.0087 14.50%
Today's


ARDS

$0.0687

$0.0087 14.50%



Aridis Pharmaceuticals Inc

Aridis Pharmaceuticals Inc stock went up 14.50% today.


Aridis Pharmaceuticals Inc. is a biopharmaceutical company that primarily focuses on developing novel antibody-based therapies for infectious diseases. They aim to develop their products through partnerships and collaborations with large pharmaceutical companies, utilizing their innovative technologies and scientific expertise.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.571 mill. $ 22.359 mill. $ -1.142 mill. 37 mill. - Y/Y 4.51 %
Market Cap. Revenues TTM Net Income TTM

$ 2.571 mill.


$ 22.359 mill.


$ -1.142 mill.

Employees Shares Outstanding P/E

-


37 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 4.51 %


MRQ Y/Y - %



RNXT

$1.35

$0.1700 14.41%
Today's


RNXT

$1.35

$0.1700 14.41%



Renovorx Inc

Renovorx Inc stock improved 14.41% today.


Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 20.179 mill. $ - mill. $ -8.051 mill. 15 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 20.179 mill.


$ - mill.


$ -8.051 mill.

Employees Shares Outstanding P/E

-


15 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NTBL

$0.774

$0.0940 13.82%
Today's


NTBL

$0.774

$0.0940 13.82%



Notable Labs Ltd

Notable Labs Ltd stock increased 13.82% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.980 mill. $ 0.311 mill. $ -17.669 mill. 9 mill. 11.06 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 6.980 mill.


$ 0.311 mill.


$ -17.669 mill.

Employees Shares Outstanding P/E

-


9 mill.


11.06

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



CMAX

$3.13

$0.3800 13.82%
Today's


CMAX

$3.13

$0.3800 13.82%



Caremax Inc

Caremax Inc shares went up 13.82% today.


Caremax Inc operates as a healthcare company providing various services and products. Their business model revolves around offering a wide range of medical and healthcare solutions, including home healthcare, medical equipment, and pharmacy services. They aim to meet the diverse needs of patients, ensuring accessible and quality healthcare options through their integrated model.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11.694 mill. $ 763.529 mill. $ -207.146 mill. 4 mill. - Y/Y 28.02 %
Market Cap. Revenues TTM Net Income TTM

$ 11.694 mill.


$ 763.529 mill.


$ -207.146 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 28.02 %


MRQ Y/Y - %



ATAO

$0.0465

$0.0056 13.69%
Today's


ATAO

$0.0465

$0.0056 13.69%



Altair International Corp

Altair International Corp shares went up 13.69% today.


Altair International Corp is a diversified company with a business model focused on providing a range of products and services. Their offerings span various sectors, including technology, finance, health, and real estate. By leveraging their expertise and network, Altair International Corp aims to capitalize on opportunities and generate revenue through strategic investments, partnerships, and market expansion.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.159 mill. $ - mill. $ -1.211 mill. 25 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.159 mill.


$ - mill.


$ -1.211 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



IKT

$1.59

$0.1800 12.77%
Today's


IKT

$1.59

$0.1800 12.77%



Inhibikase Therapeutics Inc

Inhibikase Therapeutics Inc stock increased 12.77% today.


Inhibikase Therapeutics Inc*s business model focuses on using innovative approaches and technologies to develop and commercialize potential therapeutic treatments for serious neurodegenerative diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8.494 mill. $ 0.324 mill. $ -19.130 mill. 5 mill. - Y/Y 991.33 %
Market Cap. Revenues TTM Net Income TTM

$ 8.494 mill.


$ 0.324 mill.


$ -19.130 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 991.33 %


MRQ Y/Y - %



LPCN

$10.69

$1.2000 12.64%
Today's


LPCN

$10.69

$1.2000 12.64%



Lipocine Inc

Lipocine Inc shares improved 12.64% today.


Lipocine Inc is a pharmaceutical company focused on developing oral drug delivery systems for hormone therapeutics. Their business model involves conducting research and development to create innovative products that address unmet medical needs in areas such as testosterone replacement therapy and hypogonadism. The company aims to commercialize these proprietary drug candidates and collaborate with industry partners to enhance their potential reach and impact.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 55.960 mill. $ -2.851 mill. $ -16.352 mill. 5 mill. - Y/Y 164.58 %
Market Cap. Revenues TTM Net Income TTM

$ 55.960 mill.


$ -2.851 mill.


$ -16.352 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 164.58 %


MRQ Y/Y - %



ENDV

$0.0009

$0.0001 12.50%
Today's


ENDV

$0.0009

$0.0001 12.50%



Endonovo Therapeutics Inc

Endonovo Therapeutics Inc shares increased 12.50% today.


Endonovo Therapeutics Inc is a biotechnology company focused on the development of non-invasive electroceuticals for regenerative therapies. Their business model centers around the research, development, and commercialization of their innovative technology that stimulates the body*s natural healing process. With a focus on treating inflammatory conditions and diseases, Endonovo aims to provide advanced, non-pharmaceutical solutions for improved patient outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.216 mill. $ 0.256 mill. $ -4.404 mill. 1,351 mill. - Y/Y -86.13 %
Market Cap. Revenues TTM Net Income TTM

$ 1.216 mill.


$ 0.256 mill.


$ -4.404 mill.

Employees Shares Outstanding P/E

-


1,351 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -86.13 %


MRQ Y/Y - %



EVOK

$0.5282

$0.0563 11.93%
Today's


EVOK

$0.5282

$0.0563 11.93%



Evoke Pharma Inc

Evoke Pharma Inc stock improved 11.93% today.


Evoke Pharma Inc operates as a specialty pharmaceutical company focusing on the development and commercialization of drugs for the treatment of gastrointestinal disorders. Their business model involves researching, developing, and marketing innovative pharmaceutical products to address unmet medical needs in the gastrointestinal market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.766 mill. $ 4.301 mill. $ -7.608 mill. 3 mill. - Y/Y 87.82 %
Market Cap. Revenues TTM Net Income TTM

$ 1.766 mill.


$ 4.301 mill.


$ -7.608 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 87.82 %


MRQ Y/Y - %



AEON

$1.55

$0.1600 11.51%
Today's


AEON

$1.55

$0.1600 11.51%



Aeon Biopharma inc

Aeon Biopharma Inc shares improved 11.51% today.


Aeon Biopharma Inc.*s business model focuses on the development and commercialization of biopharmaceutical products, emphasizing innovation and collaboration for the advancement of healthcare.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 95.127 mill. $ - mill. $ 4.825 mill. 61 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 95.127 mill.


$ - mill.


$ 4.825 mill.

Employees Shares Outstanding P/E

-


61 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y 451.84 %



QTI

$0.8297

$0.0847 11.37%
Today's


QTI

$0.8297

$0.0847 11.37%



Qt Imaging Holdings Inc

Qt Imaging Holdings Inc stock improved 11.37% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10.973 mill. $ 1.362 mill. $ -2.541 mill. 13 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 10.973 mill.


$ 1.362 mill.


$ -2.541 mill.

Employees Shares Outstanding P/E

-


13 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



RSPI

$0.003

$0.0003 11.11%
Today's


RSPI

$0.003

$0.0003 11.11%



Respirerx Pharmaceuticals Inc

Respirerx Pharmaceuticals Inc shares increased 11.11% today.


Respirerx Pharmaceuticals Inc is a pharmaceutical company that focuses on developing and commercializing therapeutics for the treatment of respiratory diseases. Their business model centers around research, development, and marketing of innovative respiratory drugs to improve patient outcomes and address unmet medical needs in this field.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.505 mill. $ - mill. $ -3.403 mill. 168 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.505 mill.


$ - mill.


$ -3.403 mill.

Employees Shares Outstanding P/E

-


168 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



VRPX

$0.7591

$0.0738 10.77%
Today's


VRPX

$0.7591

$0.0738 10.77%



Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc stock improved 10.77% today.


Virpax Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing innovative non-opioid products to address the unmet needs in pain management. Their business model revolves around research, development, and commercialization of these non-opioid solutions to provide effective and safe pain relief options for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.889 mill. $ - mill. $ -13.615 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.889 mill.


$ - mill.


$ -13.615 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BPTH

$2.39

$0.2300 10.65%
Today's


BPTH

$2.39

$0.2300 10.65%



Bio path Holdings Inc

Bio Path Holdings Inc stock improved 10.65% today.


Bio path Holdings Inc is a biotechnology company focused on developing RNA-based therapeutics for the treatment of diseases such as cancer. Their business model involves researching, developing, and commercializing these therapies to provide improved treatment options for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.546 mill. $ - mill. $ -13.962 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.546 mill.


$ - mill.


$ -13.962 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



OCEA

$1.56

$0.1500 10.64%
Today's


OCEA

$1.56

$0.1500 10.64%



Ocean Biomedical Inc

Ocean Biomedical Inc shares went up 10.64% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41.504 mill. $ - mill. $ -97.200 mill. 27 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 41.504 mill.


$ - mill.


$ -97.200 mill.

Employees Shares Outstanding P/E

-


27 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



VRNA

$16.66

$1.5200 10.04%
Today's


VRNA

$16.66

$1.5200 10.04%



Verona Pharma Plc

Verona Pharma Plc stock went up 10.04% today.


Verona Pharma Plc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for respiratory diseases. Their business model revolves around discovering and advancing new drug candidates, conducting clinical trials, and ultimately bringing these potential treatments to market. By leveraging their expertise in respiratory medicine, they aim to address unmet medical needs and improve the lives of patients suffering from respiratory conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10,757.379 mill. $ - mill. $ -63.420 mill. 646 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 10,757.379 mill.


$ - mill.


$ -63.420 mill.

Employees Shares Outstanding P/E

64


646 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ZJYL

$2.91

$0.2600 9.81%
Today's


ZJYL

$2.91

$0.2600 9.81%



Jin Medical International Ltd

Jin Medical International Ltd shares improved 9.81% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21.117 mill. $ 19.821 mill. $ 2.878 mill. 7 mill. 7.28 Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 21.117 mill.


$ 19.821 mill.


$ 2.878 mill.

Employees Shares Outstanding P/E

-


7 mill.


7.28

Revenue Growth Income Growth

MRQ Y/Y 0.00 %


MRQ Y/Y 0.00 %



WINT

$3.4015

$0.3015 9.73%
Today's


WINT

$3.4015

$0.3015 9.73%



Windtree Therapeutics Inc

Windtree Therapeutics Inc shares went up 9.73% today.


Windtree Therapeutics Inc is a biotechnology company that develops novel gene therapies to treat respiratory diseases by delivering therapeutic proteins to the lungs. They aim to address unmet medical needs and improve the lives of patients through their innovative treatment approaches.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.088 mill. $ - mill. $ -5.961 mill. 0 mill. 0.01 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.088 mill.


$ - mill.


$ -5.961 mill.

Employees Shares Outstanding P/E

-


0 mill.


0.01

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



HLYK

$0.09

$0.0079 9.62%
Today's


HLYK

$0.09

$0.0079 9.62%



Healthlynked Corp

Healthlynked Corp stock improved 9.62% today.


Healthlynked Corp is a healthcare network company that connects patients with physicians and other providers through their mobile application, offering various features like online appointment booking, access to medical records, and health management tools. The company generates revenue through subscription fees paid by providers to be listed on their platform and through advertising and sponsorship agreements with healthcare-related companies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 23.897 mill. $ 5.946 mill. $ -4.089 mill. 266 mill. - Y/Y -7.96 %
Market Cap. Revenues TTM Net Income TTM

$ 23.897 mill.


$ 5.946 mill.


$ -4.089 mill.

Employees Shares Outstanding P/E

-


266 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -7.96 %


MRQ Y/Y - %



NERV

$3.65

$0.3200 9.61%
Today's


NERV

$3.65

$0.3200 9.61%



Minerva Neurosciences Inc

Minerva Neurosciences Inc stock went up 9.61% today.


Minerva Neurosciences Inc is a biopharmaceutical company that primarily focuses on the development and commercialization of innovative therapies for central nervous system disorders. They aim to identify potential drug candidates, conduct clinical trials, and collaborate with partners to bring novel treatments to market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 27.627 mill. $ - mill. $ -27.709 mill. 8 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 27.627 mill.


$ - mill.


$ -27.709 mill.

Employees Shares Outstanding P/E

-


8 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %




 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com